Q&A with
Dervala Leahy,
our Head of ESG
As providers of healthcare services to many
companies in the pharmaceutical industry,
we understand the role we can play, together
with our clients, to achieve Net Zero.
Dervala Leahy,
Head of ESG
A year into Inizio’s
Sustainability Strategy,
howare things going?
We’ve made significant progress in
the last 12 months across the three
pillars of Environmental, Social, and
Governance. Under Environmental,
we’ve received validation of our
near-term science-based targets
following a detailed review by the
SBTi. These targets pave the way
forInizio to move forward, at pace,
with our decarbonization plans.
The Social pillar has also moved
forward significantly since the
appointment of our Global Head of
DEI and the development of our DEI
mission andvision statements and
our DEI Strategy. Under Governance,
we’ve made considerable progress
indeveloping the policy framework
weneed to support our new
organizational structure.
At the end of 2023, we took the
opportunity to assess our progress
andupdate our Sustainability Strategy
to reflect changes in the regulatory
environment, tighten up on some of
our earlier commitments, and to focus
on where Inizio can create the greatest
impact. These changes are detailed
within the strategy section of this
report on page 9.
How are employees
contributing to Inizio’s
Sustainability Strategy?
Our employees’ support is essential
toachieving our strategic objectives
across our three pillars. Throughout
the year, we ran various initiatives
aimed at engaging our employees
onimportant issues such as energy
consumption, mental health,and
diversity, equity, and inclusion. In
November 2023, we alsolaunched an
e-learning module on environmental
sustainability aimed at raising
awareness and inspiring change.
Aspart of this, weasked employees
to make an environmental sustainability
pledge for the next 12 months. More
than 3,100 pledges were made and
over 70% of our employees
completedthe module.
As we look to the various ESG
regulations that Inizio will soon
berequired to report against,
thesupport of colleagues in other
functions will be vital for delivering
robust and accurate ESG reporting.
What have been some
ofthebiggest drivers of
change impacting Inizio’s
sustainability efforts over
the past year?
The pharmaceutical industry
isaccelerating efforts to reach
NetZero by 2040 or earlier and
weunderstand the importance
ofpartnering with clients to
collectively achieve that goal.
Creating a sustainable organization
is also hugely important for our
employees and potential recruits,
which is why we continue to actively
involve our people in all stages of
our sustainability journey.
What are Inizio’s
sustainability priorities
for2024?
From an environmental standpoint,
our biggest challenge continues
tobe quantifying and reducing
ourScope 3 emissions. Throughout
2024, we’ll focus our engagement
program on our highest spend
suppliers first, which we’ll then
lookto evolve in the years ahead.
Employee data remains key to
thesocial pillar. We’re working
withstakeholders across HR,
Legal,and IT to advance this,
sowe’llbe in a better position to
measure our progress in the future.
In 2024, we’ll also complete our
firstdouble materiality analysis to
inform and validate our Sustainability
Strategy. This will lay the foundations
for reporting against the Corporate
Sustainability Reporting Directive
Disclosure (CSRD) and the International
Financial Reporting Standards (IFRS)
Sustainability Standards.
Highlights
70%
of our employees completed
our e-learning module on
environmental sustainability
3,100
pledges made
Inizio Sustainability Report 20235